Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yojiro Arinobu

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Arerugi = [Allergy]|September 21, 2011
[Myeloid lineage commitment from the hematopoietic stem cell]Yojiro Arinobu, Koichi Akashi
Allergology International : Official Journal of the Japanese Society of Allergology|January 21, 2009
Origin of basophils and mast cellsYojiro Arinobu, Hiromi Iwasaki, Koichi Akashi
International Journal of Hematology|November 4, 2017
Notch1 expression is regulated at the post-transcriptional level by the 3' untranslated region in hematopoietic stem cell developmentShinichi Mizuno, Tadafumi Iino, Hidetoshi Ozawa, et al.
Modern Rheumatology|June 14, 2008
Acquired hemophilia in a patient with systemic lupus erythematosus: a case report and literature reviewMitsuteru Akahoshi, Kumiko Aizawa, Shuji Nagano, et al.
Therapeutic Advances in Musculoskeletal Disease|May 19, 2022
Comparative efficacy and safety of mizoribine and mycophenolate mofetil for treating systemic lupus erythematosus: a retrospective cohort studyMasahiro Ayano, Yasutaka Kimoto, Hiroki Mitoma, et al.
Modern Rheumatology|December 11, 2021
Hydroxychloroquine versus tacrolimus for the treatment of persistently active systemic lupus erythematosusMasahiro Ayano, Yasutaka Kimoto, Hiroki Mitoma, et al.
Case Reports in Rheumatology|December 31, 2014
Transient antiphospholipid syndrome associated with primary cytomegalovirus infection: a case report and literature reviewTsuyoshi Nakayama, Mitsuteru Akahoshi, Kensuke Irino, et al.
Rheumatology International|July 28, 2018
Are the 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome applicable to patients with adult-onset Still's disease?Yoshifumi Tada, Satomi Inokuchi, Akihito Maruyama, et al.
Modern Rheumatology|August 26, 2022
Safety and efficacy of switching immunosuppressive drugs for maintenance treatment in patients with systemic lupus erythematosus: A retrospective cohort studyMasahiro Ayano, Yasutaka Kimoto, Hiroki Mitoma, et al.
The Journal of Experimental Medicine|February 27, 2008
Antagonism of FOG-1 and GATA factors in fate choice for the mast cell lineageAlan B Cantor, Hiromi Iwasaki, Yojiro Arinobu, et al.
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Arerugi = [Allergy]|September 21, 2011
[Myeloid lineage commitment from the hematopoietic stem cell]Yojiro Arinobu, Koichi Akashi
Allergology International : Official Journal of the Japanese Society of Allergology|January 21, 2009
Origin of basophils and mast cellsYojiro Arinobu, Hiromi Iwasaki, Koichi Akashi
International Journal of Hematology|November 4, 2017
Notch1 expression is regulated at the post-transcriptional level by the 3' untranslated region in hematopoietic stem cell developmentShinichi Mizuno, Tadafumi Iino, Hidetoshi Ozawa, et al.
Modern Rheumatology|June 14, 2008
Acquired hemophilia in a patient with systemic lupus erythematosus: a case report and literature reviewMitsuteru Akahoshi, Kumiko Aizawa, Shuji Nagano, et al.
Therapeutic Advances in Musculoskeletal Disease|May 19, 2022
Comparative efficacy and safety of mizoribine and mycophenolate mofetil for treating systemic lupus erythematosus: a retrospective cohort studyMasahiro Ayano, Yasutaka Kimoto, Hiroki Mitoma, et al.
Modern Rheumatology|December 11, 2021
Hydroxychloroquine versus tacrolimus for the treatment of persistently active systemic lupus erythematosusMasahiro Ayano, Yasutaka Kimoto, Hiroki Mitoma, et al.
Case Reports in Rheumatology|December 31, 2014
Transient antiphospholipid syndrome associated with primary cytomegalovirus infection: a case report and literature reviewTsuyoshi Nakayama, Mitsuteru Akahoshi, Kensuke Irino, et al.
Rheumatology International|July 28, 2018
Are the 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome applicable to patients with adult-onset Still's disease?Yoshifumi Tada, Satomi Inokuchi, Akihito Maruyama, et al.
Modern Rheumatology|August 26, 2022
Safety and efficacy of switching immunosuppressive drugs for maintenance treatment in patients with systemic lupus erythematosus: A retrospective cohort studyMasahiro Ayano, Yasutaka Kimoto, Hiroki Mitoma, et al.
The Journal of Experimental Medicine|February 27, 2008
Antagonism of FOG-1 and GATA factors in fate choice for the mast cell lineageAlan B Cantor, Hiromi Iwasaki, Yojiro Arinobu, et al.
Pageof 7